Tech Company Financing Transactions
Forward Therapeutics Funding Round
On 11/8/2023, Forward Therapeutics raised $50 million in Series A funding from BVF Partners, OrbiMed and RA Capital Management.
Transaction Overview
Company Name
Announced On
11/8/2023
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to advance its portfolio of novel, small molecule immunology medicines towards clinical development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Palm Beach Gardens,, FL Undisclosed
USA
Palm Beach Gardens,, FL Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
Forward Therapeutics is a biopharmaceutical company dedicated to transforming the treatment of chronic inflammatory disorders. Forward Therapeutics is advancing a pipeline of novel, next-generation small molecule immune therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Toufike Kanouni
Co-Founder
Ewan Taylor
Browse more venture capital transactions:
Prev: 11/7/2023: Qomodo venture capital transaction
Next: 11/8/2023: Yee-Haw Monster Trucks venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs